These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 16863739

  • 21. The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer.
    Cerfolio RJ, Bryant AS, Eloubeidi MA, Frederick PA, Minnich DJ, Harbour KC, Dransfield MT.
    Ann Thorac Surg; 2010 Aug; 90(2):427-34. PubMed ID: 20667324
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N.
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [Abstract] [Full Text] [Related]

  • 25. Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [68Ga]FAPI-46 PET/CT: a prospective pilot study.
    Kang YK, Na KJ, Park J, Kwak N, Lee YS, Choi H, Kim YT.
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2409-2419. PubMed ID: 38451308
    [Abstract] [Full Text] [Related]

  • 26. Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the 18F-FDG PET/CT mediastinal nodal staging of non-small cell lung cancer.
    Taira N, Atsumi E, Nakachi S, Takamatsu R, Yohena T, Kawasaki H, Kawabata T, Yoshimi N.
    Lung Cancer; 2018 Sep; 123():30-35. PubMed ID: 30089592
    [Abstract] [Full Text] [Related]

  • 27. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
    Lu P, Sun Y, Sun Y, Yu L.
    Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334
    [Abstract] [Full Text] [Related]

  • 28. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
    Cerfolio RJ, Bryant AS, Eloubeidi MA.
    Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
    Trister AD, Pryma DA, Xanthopoulos E, Kucharczuk J, Sterman D, Rengan R.
    Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
    [Abstract] [Full Text] [Related]

  • 31. Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
    Kubota K, Murakami K, Inoue T, Itoh H, Saga T, Shiomi S, Hatazawa J.
    Ann Nucl Med; 2011 Dec; 25(10):777-86. PubMed ID: 21901365
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT, Yang XN, Zhong WZ, Liao RQ, Dong S, Nie Q, Weng SX, Fang XJ, Zheng JY, Wu YL.
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [Abstract] [Full Text] [Related]

  • 34. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer.
    Tasci E, Tezel C, Orki A, Akin O, Falay O, Kutlu CA.
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):200-3. PubMed ID: 19933240
    [Abstract] [Full Text] [Related]

  • 35. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
    Li M, Wu N, Liang Y, Zheng R, Liu Y, Zhang WJ, Zhao P.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):288-92. PubMed ID: 19615286
    [Abstract] [Full Text] [Related]

  • 36. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
    Liu LP, Yu JM, Guo HB, Fu Z, Han AQ, Yang GR.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282
    [Abstract] [Full Text] [Related]

  • 37. Ratio between maximum standardized uptake value of N1 lymph nodes and tumor predicts N2 disease in patients with non-small cell lung cancer in 18F-FDG PET-CT scan.
    Honguero Martínez AF, García Jiménez MD, García Vicente A, López-Torres Hidalgo J, Colon MJ, van Gómez López O, Soriano Castrejón ÁM, León Atance P.
    Rev Esp Med Nucl Imagen Mol; 2016 Jun; 35(3):159-64. PubMed ID: 26514322
    [Abstract] [Full Text] [Related]

  • 38. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
    Serra Fortuny M, Gallego M, Berna L, Montón C, Vigil L, Masdeu MJ, Fernández-Villar A, Botana MI, Cordovilla R, García-Luján R, Cases E, Monsó E.
    BMC Pulm Med; 2016 Dec 08; 16(1):177. PubMed ID: 27931198
    [Abstract] [Full Text] [Related]

  • 39. [Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].
    Shao T, Yu L, Li Y, Chen M.
    Zhongguo Fei Ai Za Zhi; 2015 Mar 08; 18(3):155-60. PubMed ID: 25800571
    [Abstract] [Full Text] [Related]

  • 40. Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer.
    Cerfolio RJ, Bryant AS, Winokur TS, Ohja B, Bartolucci AA.
    Ann Thorac Surg; 2004 Dec 08; 78(6):1903-9; discussion 1909. PubMed ID: 15560998
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.